StonvexLoading…
StonvexStonvexStonvexCore line items from PRLB's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $139.34M | $533.13M | $396.63M | $261.27M |
Operating Income | $9.84M | $25.11M | $18.31M | $9.50M |
Net Income | $8.11M | $21.24M | $15.24M | $4.43M |
EPS (Diluted) | $0.33 | $0.88 | $0.63 | $0.33 |
Total Assets | $778.57M | $763.41M | $756.86M | $743.25M |
Total Liabilities | $95.44M | $89.48M | $92.14M | $78.55M |
Cash & Equivalents | $123.97M | $110.83M | $104.42M | $90.38M |
Free Cash Flow OCF − CapEx | $14.00M | $59.66M | $51.26M | $26.23M |
Shares Outstanding | 23.79M | 23.63M | 23.68M | 23.87M |